Generic Medicine
-
{
- All
- News
- Videos
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India Can Lead Global Probiotic Movement Using Traditional Diets, Says NITI Aayog's Rajiv Gauba
New Delhi, March 28 (IANS) India's rich heritage of fermented foods should be used to reverse the current shift toward ultra‑processed diets that threaten gut health and long‑term public health, Rajiv Gauba, Member, NITI Aayog, said at a probiotic sy
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India Can Lead Global Probiotic Movement Using Traditional Diets, Says NITI Aayog's Rajiv Gauba
New Delhi, March 28 (IANS) India's rich heritage of fermented foods should be used to reverse the current shift toward ultra‑processed diets that threaten gut health and long‑term public health, Rajiv Gauba, Member, NITI Aayog, said at a probiotic sy
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
